The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treated with replacement therapy, but frequent injections of the missing FVIII often lead to the formation of inhibitory antibodies. Patients who develop high levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yatuv, Rivka, Robinson, Micah, Dayan-Tarshish, Inbal, Baru, Moshe
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939703/
https://www.ncbi.nlm.nih.gov/pubmed/20856833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939703/
https://www.ncbi.nlm.nih.gov/pubmed/20856833

Ejemplares similares